TEVA logo

TEVA Shareholders Equity

Annual Shareholders Equity

$5.37 B
-$2.13 B-28.42%

December 31, 2024


Summary


Performance

TEVA Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTEVAbalance sheetmetrics:

Quarterly Shareholders Equity

$5.37 B
-$692.00 M-11.41%

December 31, 2024


Summary


Performance

TEVA Quarterly Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTEVAbalance sheetmetrics:

Shareholders Equity Formula

Shareholders Equity = Total Assets − Total Liabilities

TEVA Shareholders Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-28.4%-26.2%
3 y3 years-47.7%-40.5%
5 y5 years-61.5%-46.4%

TEVA Shareholders Equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-47.7%at low-47.7%at low
5 y5-year-61.5%at low-61.5%at low
alltimeall time-83.9%>+9999.0%-84.7%>+9999.0%

Teva Pharmaceutical Industries Limited Shareholders Equity History

DateAnnualQuarterly
Dec 2024
$5.37 B(-28.4%)
$5.37 B(-11.4%)
Sep 2024
-
$6.07 B(-4.6%)
Jun 2024
-
$6.36 B(-12.6%)
Mar 2024
-
$7.28 B(-3.0%)
Dec 2023
$7.51 B(-3.8%)
$7.51 B(+8.3%)
Sep 2023
-
$6.93 B(-1.7%)
Jun 2023
-
$7.05 B(-10.3%)
Mar 2023
-
$7.86 B(+0.7%)
Dec 2022
$7.80 B(-24.1%)
$7.80 B(-11.0%)
Sep 2022
-
$8.77 B(-3.0%)
Jun 2022
-
$9.04 B(-3.3%)
Mar 2022
-
$9.34 B(-9.1%)
Dec 2021
$10.28 B(+2.5%)
$10.28 B(-1.8%)
Sep 2021
-
$10.47 B(+1.4%)
Jun 2021
-
$10.32 B(+3.2%)
Mar 2021
-
$10.00 B(-0.3%)
Dec 2020
$10.03 B(-28.2%)
$10.03 B(+4.5%)
Sep 2020
-
$9.59 B(-30.7%)
Jun 2020
-
$13.85 B(+2.4%)
Mar 2020
-
$13.53 B(-3.2%)
Dec 2019
$13.97 B(-5.0%)
$13.97 B(+1.3%)
Sep 2019
-
$13.79 B(-2.4%)
Jun 2019
-
$14.12 B(-4.1%)
Mar 2019
-
$14.73 B(+0.2%)
Dec 2018
$14.71 B(-15.3%)
$14.71 B(-17.1%)
Sep 2018
-
$17.73 B(-1.2%)
Jun 2018
-
$17.94 B(-3.7%)
Mar 2018
-
$18.62 B(+7.3%)
Dec 2017
$17.36 B(-47.9%)
$17.36 B(-39.5%)
Sep 2017
-
$28.67 B(+2.4%)
Jun 2017
-
$27.99 B(-17.7%)
Mar 2017
-
$34.02 B(+2.1%)
Dec 2016
$33.34 B(+12.0%)
$33.34 B(-5.1%)
Sep 2016
-
$35.13 B(+16.5%)
Jun 2016
-
$30.15 B(-0.9%)
Mar 2016
-
$30.43 B(+2.2%)
Dec 2015
$29.77 B(+27.7%)
$29.77 B(+30.9%)
Sep 2015
-
$22.74 B(-1.3%)
Jun 2015
-
$23.04 B(+1.8%)
Mar 2015
-
$22.64 B(-2.9%)
Dec 2014
$23.31 B(+3.3%)
$23.31 B(-1.4%)
Sep 2014
-
$23.63 B(+0.4%)
Jun 2014
-
$23.54 B(+2.5%)
Mar 2014
-
$22.97 B(+1.8%)
Dec 2013
$22.57 B(-0.9%)
$22.57 B(+1.2%)
Sep 2013
-
$22.31 B(+3.7%)
Jun 2013
-
$21.52 B(-5.3%)
Mar 2013
-
$22.71 B(-0.2%)
Dec 2012
$22.77 B(+2.6%)
$22.77 B(-0.7%)
Sep 2012
-
$22.93 B(+0.8%)
Jun 2012
-
$22.75 B(-1.3%)
Mar 2012
-
$23.05 B(+3.9%)
Dec 2011
$22.20 B(+1.1%)
$22.20 B(-2.9%)
Sep 2011
-
$22.86 B(-3.5%)
Jun 2011
-
$23.68 B(+2.7%)
Mar 2011
-
$23.07 B(+5.1%)
Dec 2010
$21.95 B(+14.2%)
$21.95 B(+1.3%)
Sep 2010
-
$21.67 B(+12.1%)
Jun 2010
-
$19.33 B(-1.6%)
Mar 2010
-
$19.65 B(+2.2%)
DateAnnualQuarterly
Dec 2009
$19.22 B(+17.9%)
$19.22 B(-0.2%)
Sep 2009
-
$19.26 B(+8.1%)
Jun 2009
-
$17.82 B(+10.4%)
Mar 2009
-
$16.14 B(-1.0%)
Dec 2008
$16.30 B(+18.8%)
$16.30 B(+9.8%)
Sep 2008
-
$14.84 B(-1.5%)
Jun 2008
-
$15.07 B(+4.7%)
Mar 2008
-
$14.40 B(+4.9%)
Dec 2007
$13.72 B(+23.2%)
$13.72 B(+6.2%)
Sep 2007
-
$12.92 B(+7.1%)
Jun 2007
-
$12.06 B(+5.9%)
Mar 2007
-
$11.39 B(+2.2%)
Dec 2006
$11.14 B(+84.4%)
$11.14 B(+5.3%)
Sep 2006
-
$10.58 B(+6.8%)
Jun 2006
-
$9.90 B(+7.4%)
Mar 2006
-
$9.22 B(+52.6%)
Dec 2005
$6.04 B(+12.1%)
$6.04 B(+8.5%)
Sep 2005
-
$5.57 B(+4.8%)
Jun 2005
-
$5.31 B(+0.2%)
Mar 2005
-
$5.30 B(-1.7%)
Dec 2004
$5.39 B(+63.8%)
$5.39 B(+5.7%)
Sep 2004
-
$5.10 B(+13.1%)
Jun 2004
-
$4.51 B(+4.9%)
Mar 2004
-
$4.29 B(+30.6%)
Dec 2003
$3.29 B(+79.8%)
$3.29 B(+37.8%)
Sep 2003
-
$2.39 B(+8.3%)
Jun 2003
-
$2.21 B(+11.3%)
Mar 2003
-
$1.98 B(+8.3%)
Dec 2002
$1.83 B(+32.5%)
$1.83 B(+10.9%)
Sep 2002
-
$1.65 B(+4.1%)
Jun 2002
-
$1.58 B(+9.4%)
Mar 2002
-
$1.45 B(+4.8%)
Dec 2001
$1.38 B(+19.9%)
$1.38 B(+4.5%)
Sep 2001
-
$1.32 B(+5.6%)
Jun 2001
-
$1.25 B(+6.4%)
Mar 2001
-
$1.17 B(+2.0%)
Dec 2000
$1.15 B(+54.1%)
$1.15 B(+5.3%)
Sep 2000
-
$1.09 B(+2.4%)
Jun 2000
-
$1.07 B(+38.5%)
Mar 2000
-
$771.04 M(+3.2%)
Dec 1999
$747.23 M(+13.4%)
$747.23 M(+5.3%)
Sep 1999
-
$709.30 M(+1.8%)
Jun 1999
-
$696.50 M(+3.5%)
Mar 1999
-
$673.20 M(+2.2%)
Dec 1998
$658.80 M(+7.6%)
$658.80 M(-0.5%)
Sep 1998
-
$662.20 M(+3.3%)
Jun 1998
-
$641.00 M(+1.7%)
Mar 1998
-
$630.30 M(+3.0%)
Dec 1997
$612.00 M(+14.6%)
$612.00 M(+14.6%)
Dec 1996
$534.20 M(+10.7%)
$534.20 M(+10.7%)
Dec 1995
$482.50 M(+41.1%)
$482.50 M(+41.1%)
Dec 1994
$342.00 M(+27.9%)
$342.00 M(+27.9%)
Dec 1993
$267.50 M(+20.3%)
$267.50 M(+20.3%)
Dec 1992
$222.30 M(+21.9%)
$222.30 M(+21.9%)
Dec 1991
$182.40 M(+34.5%)
$182.40 M(+34.5%)
Dec 1990
$135.60 M(+13.6%)
$135.60 M(+13.6%)
Dec 1989
$119.40 M(+20.5%)
$119.40 M(+20.5%)
Dec 1988
$99.10 M(+71.5%)
$99.10 M(+71.5%)
Mar 1987
$57.80 M(+15.8%)
$57.80 M(+15.8%)
Mar 1986
$49.90 M
$49.90 M

FAQ

  • What is Teva Pharmaceutical Industries Limited annual stockholders equity?
  • What is the all time high annual shareholders equity for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited annual shareholders equity year-on-year change?
  • What is Teva Pharmaceutical Industries Limited quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited quarterly shareholders equity year-on-year change?

What is Teva Pharmaceutical Industries Limited annual stockholders equity?

The current annual shareholders equity of TEVA is $5.37 B

What is the all time high annual shareholders equity for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high annual stockholders equity is $33.34 B

What is Teva Pharmaceutical Industries Limited annual shareholders equity year-on-year change?

Over the past year, TEVA annual stockholders equity has changed by -$2.13 B (-28.42%)

What is Teva Pharmaceutical Industries Limited quarterly stockholders equity?

The current quarterly shareholders equity of TEVA is $5.37 B

What is the all time high quarterly shareholders equity for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high quarterly stockholders equity is $35.13 B

What is Teva Pharmaceutical Industries Limited quarterly shareholders equity year-on-year change?

Over the past year, TEVA quarterly stockholders equity has changed by -$1.91 B (-26.17%)